Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.

Tanaka T, Asakura S, Hisamatsu K, Fujimoto N

Open source

DOI
10.1016/j.jtocrr.2022.100351
Published
2022 Jul
Container
JTO clinical and research reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2022.100351,
  title = {Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.},
  author = {Tanaka T and Asakura S and Hisamatsu K and Fujimoto N},
  year = {2022},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2022.100351},
  url = {https://doi.org/10.1016/j.jtocrr.2022.100351}
}

RIS

TY  - JOUR
TI  - Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.
AU  - Tanaka T
AU  - Asakura S
AU  - Hisamatsu K
AU  - Fujimoto N
PY  - 2022
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2022.100351
UR  - https://doi.org/10.1016/j.jtocrr.2022.100351
ER  - 

APA

T, T., S, A., K, H., & N, F. (2022). Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2022.100351

Source records